Covered recipient · General Payments record
CYNTHIA RENEE JAMISON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,916.15
- Reported across 194 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.33 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $125.40 | 1 |
| Lilly USA, LLC | $115.03 | 6 |
| Abbott Laboratories | $23.91 | 1 |
| GlaxoSmithKline, LLC. | $19.58 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.54 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.80 | 1 |
| Novo Nordisk AS | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.91 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124798420 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.40 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105677905 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.80 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101223160 | CMS |
| GlaxoSmithKline, LLC. | $19.58 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116543396 | CMS |
| Lilly USA, LLC | $16.62 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136123210 | CMS |
| Lilly USA, LLC | $15.20 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136134569 | CMS |
| Lilly USA, LLC | $23.87 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136105977 | CMS |
| Lilly USA, LLC | $17.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136123212 | CMS |
| Lilly USA, LLC | $20.01 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136114718 | CMS |
| Lilly USA, LLC | $22.33 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136127355 | CMS |
| Novartis Pharmaceuticals Corporation | $19.54 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087153182 | CMS |
| Novo Nordisk Inc | $13.07 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096715395 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.